Urinalysis Market Developments and Forecast by 2028

The urinalysis market is projected to reach US$ 5,937.97 million by 2028 from US$ 4,065.79 million in 2021; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.  

A urinalysis is used in the diagnosis and management of various disorders such as kidney disease, urinary tract infections, and diabetes. It is the analysis of urine by chemical, physical, and microscopical means to check for the presence of drugs and disease-related entities, including biomolecules or other by-products, in it. The urinalysis includes checking the concentration, appearance, and content of urine. In urinalysis, abnormal results or estimations out of the expected range may indicate an illness or disease. If the urine test result is positive, it may point that kidneys are not functioning or filtering the blood in the manner as they should. It might also help in the diagnosis of cardiovascular disease, and detection of pregnancy and ovulation.

The urinalysis market has been segmented on the basis of product, test type, application, end user, and geography. Based on geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the urinalysis market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with competitive landscape analysis of the globally leading market players.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Urinalysis Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Growing Burden of Urinary Tract Infection, Diabetes, and Kidney Diseases Boosts Urinalysis Market Growth

As per the study reported by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, ~6 million people in the US visit physicians for the treatment of urinary tract infection (UTIs) every year. Women are at a higher risk of developing UTIs than men. According to a study published in the International Journal of Environmental Research and Public Health in 2019, patients with existing chronic conditions, such as diabetes mellitus (DM), are at a greater risk of acquiring UTIs. The demand for components required for urinalysis is rising due to the common occurrence of diabetes across the world, as the primary screening for diabetes involves urinalysis. As per the International Diabetes Federation (IDF), ~463 million adults (age 20–79 years) in the world were living with diabetes in 2019; this number is likely to rise to 700 million by 2045. According to the IDF, ~87.6 million adults of age 20–79 was living with diabetes in Southeast Asia in 2019, representing a regional prevalence of 8.8%, and ~56.7% of these diabetes cases were undiagnosed, this shows there is potential for market development of urinalysis. Moreover, according to a study published by the National Kidney Foundation in 2020, ~35.0% of the diabetic population above age 20 would develop chronic kidney diseases over the period. An ongoing surge in the prevalence of prostate and bladder cancer raises a strong therapeutic imperative for the implementation of highly effective diagnostics.

Thus, the escalating prevalence of UTIs, diabetes, and kidney diseases boosts urinalysis market growth.   

Product-Based Insights

Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021, and it is further anticipated to register a higher CAGR during the forecast period.

Test Type-Based Insights

The urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021, and it is estimated to register the highest CAGR in the market during 2021–2028. 

Application-Based Insights

Based on application, the urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The market for the same segment is estimated to grow at a higher CAGR from 2021 to 2028.

End User-Based Insights

The urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021, while the diagnostic laboratories segment is estimated to register the highest CAGR during the forecast period. 

COVID-19 has presented the most significant global health emergency till date. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of instruments, consumables, and reagents. The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to the lockdown announced by most European countries. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement.   

Acquisitions, collaborations, partnerships, product launches, and expansions are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The urinalysis market players have been chiefly adopting the strategy of product innovation to cater to the changing customer demands across the world, which also helps them maintain their brand name globally.

Urinalysis Market Regional Insights

The regional trends and factors influencing the Urinalysis Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Urinalysis Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Urinalysis Market Report Scope

Urinalysis Market Players Density: Understanding Its Impact on Business Dynamics

The Urinalysis Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Urinalysis Market are:

1. Abbott
2. ACON Laboratories, Inc.
3. ARKRAY, Inc.
4. Beckman Coulter, Inc.
5. Bio-Rad Laboratories Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

 

Company Profiles

• Abbott        
• ACON Laboratories, Inc.                        
• ARKRAY, Inc.                                       
• Beckman Coulter, Inc.                          
• Bio-Rad Laboratories Inc.                      
• Cardinal Health Inc                              
• F. Hoffmann-La Roche Ltd.                   
• Quidel Corporation                               
• Siemens Healthineers AG                      
• Sysmex Corporation